- Home
- PHAR vs EIM Comparison
PHAR vs EIM Comparison
Compare PHAR & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- EIM
- Stock Information
- Founded
- PHAR 1988
- EIM 2002
- Country
- PHAR Netherlands
- EIM United States
- Employees
- PHAR N/A
- EIM N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- EIM Finance/Investors Services
- Sector
- PHAR Health Care
- EIM Finance
- Exchange
- PHAR Nasdaq
- EIM Nasdaq
- Market Cap
- PHAR 627.5M
- EIM 584.0M
- IPO Year
- PHAR N/A
- EIM N/A
- Fundamental
- Price
- PHAR $9.98
- EIM $10.19
- Analyst Decision
- PHAR Strong Buy
- EIM
- Analyst Count
- PHAR 3
- EIM 0
- Target Price
- PHAR $27.00
- EIM N/A
- AVG Volume (30 Days)
- PHAR 5.6K
- EIM 215.2K
- Earning Date
- PHAR 03-13-2025
- EIM 01-01-0001
- Dividend Yield
- PHAR N/A
- EIM 4.32%
- EPS Growth
- PHAR N/A
- EIM N/A
- EPS
- PHAR N/A
- EIM N/A
- Revenue
- PHAR $285,745,000.00
- EIM N/A
- Revenue This Year
- PHAR $20.08
- EIM N/A
- Revenue Next Year
- PHAR $9.22
- EIM N/A
- P/E Ratio
- PHAR N/A
- EIM N/A
- Revenue Growth
- PHAR 30.64
- EIM N/A
- 52 Week Low
- PHAR $6.65
- EIM $8.61
- 52 Week High
- PHAR $13.20
- EIM $10.51
- Technical
- Relative Strength Index (RSI)
- PHAR 56.13
- EIM 34.66
- Support Level
- PHAR $9.37
- EIM $10.15
- Resistance Level
- PHAR $10.15
- EIM $10.36
- Average True Range (ATR)
- PHAR 0.50
- EIM 0.12
- MACD
- PHAR -0.09
- EIM -0.01
- Stochastic Oscillator
- PHAR 57.53
- EIM 8.75
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About EIM Eaton Vance Municipal Bond
Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.